Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lusher

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
JAMA|June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapyG F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2000
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophiliaM V Ragni, J M Lusher, M A Koerper, et al.
Thrombosis and Haemostasis|April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and HaemostasisG C White, F Rosendaal, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study GroupS Seremetis, J M Lusher, C F Abildgaard, et al.
JAMA|December 13, 1971
Sickledex test for hemoglobin S. A critiqueR M Nalbandian, N L Henry, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical proceduresA D Shapiro, G C White Ii, H C Kim, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2009
Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patientsM Rajpurkar, K Boldt-Macdonald, R McLenon, et al.
Blood|February 1, 1974
Macroglobulinemia in a child with acute leukemiaJ Cejka, R O Bollinger, H R Schuit, et al.
Haematologica|February 24, 2001
Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitorsB M Ewenstein, W K Hoots, J M Lusher, et al.
Lancet (London, England)|February 27, 1993
Passive antibody to hepatitis A virus in US haemophiliacsM J Nowicki, J W Mosley, M A Koerper, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
JAMA|June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapyG F Pierce, J M Lusher, A P Brownstein, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2000
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophiliaM V Ragni, J M Lusher, M A Koerper, et al.
Thrombosis and Haemostasis|April 20, 2001
Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and HaemostasisG C White, F Rosendaal, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy. The KOGENATE Study GroupS Seremetis, J M Lusher, C F Abildgaard, et al.
JAMA|December 13, 1971
Sickledex test for hemoglobin S. A critiqueR M Nalbandian, N L Henry, J M Lusher, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical proceduresA D Shapiro, G C White Ii, H C Kim, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2009
Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patientsM Rajpurkar, K Boldt-Macdonald, R McLenon, et al.
Blood|February 1, 1974
Macroglobulinemia in a child with acute leukemiaJ Cejka, R O Bollinger, H R Schuit, et al.
Haematologica|February 24, 2001
Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitorsB M Ewenstein, W K Hoots, J M Lusher, et al.
Lancet (London, England)|February 27, 1993
Passive antibody to hepatitis A virus in US haemophiliacsM J Nowicki, J W Mosley, M A Koerper, et al.
Pageof 14